久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Basic Info

  • Grade: Research grade

    Factory Location: Hangzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: hundreds of grams

    Packaging Information: 500mg,1g, 10g,50g 100g?per?package with icebag

  • Delivery Lead Time: In stock or 2-3weeks

    Sample Provided: yes

    Payment Terms: T/T

    Cilengitide is a cyclic peptide containing the RGD sequence. The peptide is based on the in vivo αv β3 integrin ligand, and is obtained through a comprehensive use of cyclization, spatial screening and methylation scanning, and has high affinity and selectivity for αv β3 integrin. Tests have shown that the peptide not only can better inhibit the growth of melanoma and glioma, but also can improve the cure rate of other tumors such as head and neck squamous cell tumors when combined with radiotherapy. It has a good market prospect and potential. In peptide synthesis, Cilengitide is produced through a combination of solid-phase peptide synthesis technology and liquid-phase peptide synthesis technology.
Send your message to this supplier
  • From:
  • To:
    Hangzhou Go Top Peptide Biotech Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service